Desmopressin vs placebo
Desmopressin showed no clear difference in major adverse events compared with placebo (low certainty).
- RR 3.05 [0.13, 73.39]1 study · 115 participantsLow
- RR 0.97 [0.1, 9.03]2 studies · 536 participantsVery low
Desmopressin showed no clear difference in major adverse events compared with placebo (low certainty).
Desmopressin showed no clear difference in minor adverse events compared with placebo (low certainty).
It is very uncertain whether desmopressin changes minor adverse events compared with alpha‐blocker (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Desmopressin plus alpha‐blocker showed no clear difference in major adverse events compared with alpha‐blocker (low certainty).
It is very uncertain whether desmopressin plus alpha‐blocker changes minor adverse events compared with alpha‐blocker (very low certainty).
Desmopressin plus alpha‐blocker may leads to lower minor adverse events compared with alpha‐blocker plus anticholinergic (low certainty).